(Q48177455)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

In vivo dynamic distribution of 131I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Essam Refai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

A Eskilsson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C Nilsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C Jonsson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

H Jacobsson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

S Larsson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

S Efendic

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

Nuclear Medicine and Biology

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

413-420

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

Glucagon-like peptide-1(7-36)amide induces the release of aspartic acid and glutamine by the ventromedial hypothalamus of the conscious rat

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Structural characterization by affinity cross-linking of glucagon-like peptide-1(7-36)amide receptor in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Subcutaneous glucagon-like peptide I combined with insulin normalizes postcibal glycemic excursions in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Comparison of half-disappearance times, distribution volumes and metabolic clearance rates of exogenous glucagon-like peptide 1 and glucagon in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Renal catabolism of truncated glucagon-like peptide 1

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Lipolytic action of glucagon-like peptides in isolated rat adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Glucagon-like peptide-1 binding to rat hepatic membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900121-8

7 January 2021

10.1016/S0969-8051(98)00121-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382845%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference